Back to search

Article

Single cell multi-omics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response

2023-08-18

Abstract excerpt

The advent of tyrosine kinase inhibitors (TKIs) as treatment of chronic myeloid leukemia (CML) is a paradigm in molecularly targeted cancer therapy. Nonetheless, TKI insensitive leukemia stem cells (LSCs) persist in most patients even after years of treatment. The sustained presence, heterogeneity and evolvability of LSCs are imperative for disease progression as well as recurrence during treatment-free remission...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1570bb5d-9697-5d77-98a4-2a87ed31daf4
DOI
10.1101/2023.08.16.553504
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Single cell multi-omics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy responseDOI 10.1101/2023.08.16.553504
Select a neighboring publication to make it the new centre.